• Company
• Keytruda indication has been expanded
• by Jul 26, 2022 06:05am

• Company
• Evusheld can be prescribed in Korea
• by Eo, Yun-Ho Jul 26, 2022 06:05am

• Company
• EC market, occupied more than 70% of Bayer and Hyundai
• by Nho, Byung Chul Jul 25, 2022 05:58am

• Company
• He Young Lee appointed new head of BMS Korea
• by Eo, Yun-Ho Jul 25, 2022 05:57am

• Company
• Heart failure guidelines revised for the first time in 6 yrs
• by Jul 25, 2022 05:57am

• Policy
• Paxlovid·Lagevio, the effect of inhibiting viral proliferat
• by Kim, Jung-Ju Jul 25, 2022 05:57am

• Company
• How will the prescription market react?
• by Chon, Seung-Hyun Jul 25, 2022 05:57am

• Policy
• Donepezil patch is cheaper than 99 existing formulations
• by Lee, Tak-Sun Jul 22, 2022 05:53am

• Company
• Strong dollar slows sales of Epis’s 3 biosimilars in Europe
• by Jul 22, 2022 05:53am

• Policy
• Drug e-labeling and abolition of PMS reexaminations...
• by Lee, Hye-Kyung Jul 22, 2022 05:53am